you are here: Home News Gilead Sciences

Gilead Sciences

Dr Reddy’s enters pact with Gilead Sciences to manufacture, sell HIV drug Lenacapavir in India and 120 countries
Cognizant extends $800 million IT deal with Gilead Sciences
Gilead nears deal to buy Immunomedics for more than $20 billion: Report
Pfizer signs deal to manufacture and supply Gilead's remdesivir for COVID-19 treatment
Gilead's COVID-19 antiviral remdesivir gets conditional EU clearance
Coronavirus pandemic | Gilead Sciences will not launch remdesivir in India in July: Report
Coronavirus drug | Dr Reddy's inks pact with Gilead Sciences to manufacture remdesivir
AstraZeneca contacted Gilead over potential megamerger: Report
COVID-19 treatment | Gilead says Indian licensees free to price Remdesivir: Report
US pharma giant seeks marketing authorisation from India for potential COVID-19 treatment drug
Cipla: Respiratory pipeline adds oxygen, accumulate
Health groups ask India to rescind Gilead's patents for COVID-19 drug remdesivir
Iran-linked hackers recently targeted coronavirus drugmaker Gilead
Japan approves Gilead Sciences' remdesivir as COVID-19 drug
Exclusive: Gilead says open to collaborate with govts, drug firms to make Remdesivir globally available
US FDA moving with 'lightning speed' on Gilead's COVID-19 drug: Report
US stock index futures jump after Gilead's COVID-19 drug meets main goal
Gilead puts emergency access to experimental coronavirus drug on hold amid surging demand
Editor's Take | Drug companies in race to find vaccine and eliminate COVID-19
Gilead warns against Hep C drugs from buyers clubs, says patients may be at risk
Cipla, Godrej Consumer Products in 'Change the World' list
Natco gets DCGI nod to launch hepatitis C drug in India
Gilead Sciences to set up manufacturing unit in Hyderabad
Battle coming for blockbuster cholesterol drugs
Mylan launches Sovaldi tablets in India

English

Markets

News

Personal Finance

Mutual Funds

Commodities

Media

Invest Now

Specials

Gilead Sciences

Dr Reddy’s enters pact with Gilead Sciences to manufacture, sell HIV drug Lenacapavir in India and 120 countries

Cognizant extends $800 million IT deal with Gilead Sciences

Gilead nears deal to buy Immunomedics for more than $20 billion: Report

Pfizer signs deal to manufacture and supply Gilead's remdesivir for COVID-19 treatment

Gilead's COVID-19 antiviral remdesivir gets conditional EU clearance

Coronavirus pandemic | Gilead Sciences will not launch remdesivir in India in July: Report

Coronavirus drug | Dr Reddy's inks pact with Gilead Sciences to manufacture remdesivir

AstraZeneca contacted Gilead over potential megamerger: Report

COVID-19 treatment | Gilead says Indian licensees free to price Remdesivir: Report

US pharma giant seeks marketing authorisation from India for potential COVID-19 treatment drug

Cipla: Respiratory pipeline adds oxygen, accumulate

Health groups ask India to rescind Gilead's patents for COVID-19 drug remdesivir

Iran-linked hackers recently targeted coronavirus drugmaker Gilead

Japan approves Gilead Sciences' remdesivir as COVID-19 drug

Exclusive: Gilead says open to collaborate with govts, drug firms to make Remdesivir globally available

US FDA moving with 'lightning speed' on Gilead's COVID-19 drug: Report

US stock index futures jump after Gilead's COVID-19 drug meets main goal

Gilead puts emergency access to experimental coronavirus drug on hold amid surging demand

Editor's Take | Drug companies in race to find vaccine and eliminate COVID-19

Gilead warns against Hep C drugs from buyers clubs, says patients may be at risk

Cipla, Godrej Consumer Products in 'Change the World' list

Natco gets DCGI nod to launch hepatitis C drug in India

Gilead Sciences to set up manufacturing unit in Hyderabad

Battle coming for blockbuster cholesterol drugs

Mylan launches Sovaldi tablets in India